Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy
Hereditary Cancer in Clinical Practice - United Kingdom
doi 10.1186/1897-4287-13-s1-a4
Full Text
Open PDFAbstract
Available in full text
Date
September 9, 2015
Authors
Publisher
Springer Science and Business Media LLC